We are live on ! Find out more
EVH icon

Evolent Health

155 hedge funds and large institutions have $997M invested in Evolent Health in 2020 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 37 increasing their positions, 53 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $5.88M | Put options by funds: $2.54M

85% more capital inflows, than outflows

Capital inflows: $186M | Capital outflows: $100M

78% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 23

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more funds holding

Funds holding: 136 → 155 (+19)

7.45% more ownership

Funds ownership: 85.95% → 93.39% (+7.4%)

30% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 53

Holders
155
Holders Change
+19
Holders Change %
+13.97%
% of All Funds
3.12%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
41
Increased
37
Reduced
53
Closed
23
Calls
$5.88​M
Puts
$2.54​M
Net Calls
+$3.34​M
Net Calls Change
+$3.31​M

EVH Hedge Fund Activity: Q3 2020 in Review

155 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2020, worth a combined $997M — up 91% from $522M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new EVH positions and 23 closed out — a net gain of 18 holders — while 37 added to existing stakes and 53 trimmed.

The largest buyer was Engaged Capital, opening a new position worth an estimated $101M. The largest seller was Bellevue Group, cutting an estimated $20.6M.

  • 155 institutional investors held Evolent Health (EVH) as of Q3 2020, up from 136 in Q2 2020.
  • Funds reported $997M of Evolent Health stock for Q3 2020, up 91% quarter-over-quarter.
  • 41 funds opened new Evolent Health positions in Q3 2020 and 23 closed out, a net change of +18 holders.
  • The largest Evolent Health buyer in Q3 2020 was Engaged Capital, an estimated $101M added.
  • The largest Evolent Health seller in Q3 2020 was Bellevue Group, an estimated $20.6M sold.

Based on aggregated 13F filings for Q3 2020.